Langasog, Rudy S.
HRN: 23-51-55 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
CEFTRIAXONE 1G (VIAL)
08/07/2023
08/14/2023
IV
2 Grams
OD
PTB; CAP MR
Checking Final Appropriateness
08/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/07/2023
08/07/2023
IV
4.5
Now
CAP MR
Checking Final Appropriateness
08/09/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/09/2023
08/15/2023
IV
2.25gm
Q8
Acute Pyelonephritis
Checking Final Appropriateness